These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
686 related items for PubMed ID: 18042068
1. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E. Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068 [Abstract] [Full Text] [Related]
2. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer]. Fu XR, Zhang C, Chen CY, Zhang L, Wang LX, Wang BH, Liu XY, Zhang MZ. Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459 [Abstract] [Full Text] [Related]
3. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]. Zhou CY, Yao JF, Chen XD. Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097 [Abstract] [Full Text] [Related]
4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN. J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [Abstract] [Full Text] [Related]
5. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival. Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H. Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476 [Abstract] [Full Text] [Related]
6. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]. Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ. Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934 [Abstract] [Full Text] [Related]
14. Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma. Roh MR, Zheng Z, Kim HS, Kwon JE, Jeung HC, Rha SY, Chung KY. Exp Mol Pathol; 2012 Apr; 92(2):236-42. PubMed ID: 22305927 [Abstract] [Full Text] [Related]
16. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Giannopoulos G, Pavlakis K, Parasi A, Kavatzas N, Tiniakos D, Karakosta A, Tzanakis N, Peros G. Anticancer Res; 2008 Apr; 28(3B):1875-81. PubMed ID: 18630474 [Abstract] [Full Text] [Related]
19. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance. Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J. Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148 [Abstract] [Full Text] [Related]